OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Cytokinetics Inc/  US23282W6057  /

NASDAQ
2024-04-24  10:00:00 PM Chg. +1.2500 Volume Bid1:47:47 AM Ask1:47:47 AM High Low
66.8200USD +1.91% 807,781
Turnover: 34.71 mill.		 66.0000Bid Size: 100 67.5000Ask Size: 100 67.4500 65.6800
GlobeNewswire 04-24 Cytokinetics to Announce First Quarter Results on May 8, 2024
GlobeNewswire 04-10 Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at t...
GlobeNewswire 04-05 Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Stu...
GlobeNewswire 04-05 Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Stu...
GlobeNewswire 04-02 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 04-01 Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 03-25 Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual...
GlobeNewswire 03-04 Cytokinetics to Participate in March Investor Conferences
GlobeNewswire 03-01 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 02-29 Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
GlobeNewswire 02-28 Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase E...
GlobeNewswire 02-27 Cytokinetics Reports Fourth Quarter 2023 Financial Results
GlobeNewswire 02-15 Royalty Pharma Reports Q4 and Full Year 2023 Results
GlobeNewswire 02-13 Cytokinetics to Announce Fourth Quarter Results on February 27, 2024
GlobeNewswire 02-06 Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire 01-29 Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program
GlobeNewswire 01-25 Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial...
GlobeNewswire 01-18 Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024
GlobeNewswire 01-03 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 01-02 Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-12-27 Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Afi...
GlobeNewswire 2023-12-26 Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, t...
GlobeNewswire 2023-12-12 Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support F...
GlobeNewswire 2023-12-07 Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND
GlobeNewswire 2023-12-01 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)